Overview of nanoparticulate strategies for solubility enhancement of poorly soluble drugs
KU Khan, MU Minhas, SF Badshah, M Suhail, A Ahmad… - Life Sciences, 2022 - Elsevier
Poor aqueous solubility and poor bioavailability are major issues with many pharmaceutical
industries. By some estimation, 70–90% drug candidates in development stage while up-to …
industries. By some estimation, 70–90% drug candidates in development stage while up-to …
The formation of host–guest complexes between surfactants and cyclodextrins
AJM Valente, O Söderman - Advances in Colloid and Interface Science, 2014 - Elsevier
Cyclodextrins are able to act as host molecules in supramolecular chemistry with
applications ranging from pharmaceutics to detergency. Among guest molecules surfactants …
applications ranging from pharmaceutics to detergency. Among guest molecules surfactants …
Co-amorphous systems for the delivery of poorly water-soluble drugs: Recent advances and an update
J Han, Y Wei, Y Lu, R Wang, J Zhang… - Expert opinion on drug …, 2020 - Taylor & Francis
Introduction Most new drug candidates under development are poorly water-soluble, which
are related to multiple pharmaceutical issues, increasing the bioavailability of these drugs by …
are related to multiple pharmaceutical issues, increasing the bioavailability of these drugs by …
Cyclodextrin/surfactant inclusion complexes: An integrated view of their thermodynamic and structural properties
LSS Araújo, G Lazzara, L Chiappisi - Advances in Colloid and Interface …, 2021 - Elsevier
Cyclodextrins (CDs) play an important role in self-assembly systems of amphiphiles. The
structure of CDs provides distinguished physicochemical properties, including the ability to …
structure of CDs provides distinguished physicochemical properties, including the ability to …
Dihydroergotamine mesylate-loaded dissolving microneedle patch made of polyvinylpyrrolidone for management of acute migraine therapy
Migraine is a widespread neurological disease with negative effects on quality of life and
productivity. Moderate to severe acute migraine attacks can be treated with …
productivity. Moderate to severe acute migraine attacks can be treated with …
Formulation and evaluation of simvastatin polymeric nanoparticles loaded in hydrogel for optimum wound healing purpose
U Farghaly Aly, HA Abou-Taleb… - Drug design …, 2019 - Taylor & Francis
Purpose The aim of this study was to formulate a hydrogel loaded with polymeric
nanoparticles (PoNPs) of simvastatin (SIM) for topical wound healing application. Materials …
nanoparticles (PoNPs) of simvastatin (SIM) for topical wound healing application. Materials …
Poly (l-lactic acid)-based modified nanofibrous membrane with dual drug release capability for GBR application
Electrospun multilayer nanofibers guided bone regeneration (GBR) with a new design were
developed in this study. The synthesized multilayer GBR was composed of two distinct …
developed in this study. The synthesized multilayer GBR was composed of two distinct …
Preparation of solid dispersions of simvastatin and soluplus using a single-step organic solvent-free supercritical fluid process for the drug solubility and dissolution …
The study was designed to investigate the feasibility of supercritical carbon dioxide (scCO2)
processing for the preparation of simvastatin (SIM) solid dispersions (SDs) in …
processing for the preparation of simvastatin (SIM) solid dispersions (SDs) in …
Novel water-soluble fisetin/cyclodextrins inclusion complexes: Preparation, characterization, molecular docking and bioavailability
J Zhang, K Jiang, K An, SH Ren, X Xie, Y Jin… - Carbohydrate research, 2015 - Elsevier
Novel water-soluble inclusion complexes for fisetin (FIT) were developed by introducing β-
cyclodextrin (β-CD) and γ-CD. Properties of the obtained complexes, as well as the …
cyclodextrin (β-CD) and γ-CD. Properties of the obtained complexes, as well as the …
A screening study for the development of simvastatin-doxorubicin liposomes, a co-formulation with future perspectives in colon cancer therapy
An increasing number of studies published so far have evidenced the benefits of Simvastatin
(SIM) and Doxorubicin (DOX) co-treatment in colorectal cancer. In view of this, the current …
(SIM) and Doxorubicin (DOX) co-treatment in colorectal cancer. In view of this, the current …